Aurobindo Pharma inks product development deal with global pharma companyThe agreement is for the development and commercialization of specific products across the respiratory therapeutic category. Dr. Reddy’s, Senores Pharmaceuticals launch generic StromectolGeneric Stromectol is an antiparasitic medicine used to treat certain infections. Formosa, DÁVI ink deal for clobetasol propionate ophthalmic suspension Clobetasol propionate ophthalmic suspension is used to treat inflammation and pain following ocular surgery. Lundbeck to acquire Longboard Longboard is a clinical-stage biopharmaceutical company focused on developing medicines for neurological diseases. NEOM Wellbeing launches at Ulta The brand’s aromatherapy products for the home, bath, body and skin are now available at the beauty retailer. Kenvue taps Andrew Stanleick as president of skin health & beauty, North America, Europe, Middle East, Africa Stanleick will lead the strategic direction of Kenvue's portfolio of brands, including Neutrogena, Aveeno and OGX, in the regions. Cencora makes 2 senior appointments Francois Mandeville was named executive vice president, strategy and M&A; Pawan Verma was named executive vice president, chief data and information officer. Meitheal Pharmaceuticals secures exclusive commercial licensing agreement for 3 biosimilars The agreement covers biosimilars for oncology and fertility medications. Lupin taps Claus Jepsen as president, global specialty Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the global strategy for rare diseases. Natco Pharma’s partner Mylan settles Ozempic patent dispute The terms of the agreement remain confidential. First Previous 1 2 3 4 5 Next Last
